BHVN Research and Charts

BHVN - Biohaven Pharmaceutical Holding Co Ltd (Healthcare: Biotechnology)

Projected Earnings Date: 2023-11-05 (Delayed quote data 2026-02-10)

Last 12.19	Change ⇓ -0.58 (-4.54%)	Volume 2,257,298
	Open 13.00	High 13.08	Low 12.11

8EMA (Daily) 11.92	40EMA (Daily) 11.75	50EMA (Daily) 11.78	STO (Daily) 30.124	MACD Hist (Daily) -0.017
8EMA (Weekly) 11.953	40EMA (Weekly) 15.61	50EMA (Weekly) 17.27	STO (Weekly) 52.583	MACD Hist (Weekly) 0.405


Company Profile
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.